Edition:
United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

26.75HKD
16 Aug 2019
Change (% chg)

HK$0.60 (+2.29%)
Prev Close
HK$26.15
Open
HK$26.10
Day's High
HK$26.90
Day's Low
HK$25.70
Volume
5,607,582
Avg. Vol
6,194,213
52-wk High
HK$41.05
52-wk Low
HK$25.70

Liu, Yong 

Mr. Liu Yong serves as President, Executive Director of the Company. Mr. Liu joined the Group in January 2003, he has served as the Group’s president since November 2017 and executive director since December 2017. Mr. Liu has over 26 years of working experience, over 23 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Liu obtained a bachelor’s degree in science, majoring in business administration of pharmaceutical enterprises, from China Pharmaceutical University in July 1992, a master’s degree in business administration from Fudan University in January 2000 and a doctoral degree in social and administrative pharmacy from China Pharmaceutical University in June 2016. Mr. Liu is a chief pharmacist and a practicing pharmacist. Mr. Liu was employed at Shanghai Pharmaceutical Station from July 1992 to July 1999, and served as the deputy general manager at the marketing department of China National Pharmaceutical Group Shanghai Corporation and the deputy general manager of Shanghai Guoda Drug Chain Store Co., Ltd. from July 1999 to April 2003. Mr. Liu was the general manager and secretary of Party Committee of Sinopharm Holding Shenyang Co., Ltd. from April 2003 to November 2009. He served as vice president of the Company from January 2009 to November 2017, secretary to the Board of the Company from October 2016 to November 2017, and has served as chief legal advisor of the Company from January 2014 to December 2017. Mr. Liu is currently the director of Sinopharm Industrial Investment Co., Ltd. and Sinopharm Holding Guoda Drugstores Co., Ltd., and chairman of Sinopharm Lerentang Pharmaceutical Co., Ltd. and China National Accord Medicines Co., Ltd.

Basic Compensation

Total Annual Compensation, CNY 7,379,000
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY 110,000
Fiscal Year Total, CNY 7,489,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li

6,572,000

Yong Liu

7,489,000

Qiyu Chen

--

Xiuchang Jiang

--

Maisong Cai

--

Jun Lu

--
As Of  31 Dec 2017